Nasdaq · Healthcare
Fortrea Holdings Inc. (FTRE)
As-reported financials and recent SEC filings for Fortrea Holdings Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$2.72B
Net income
$-986.2M
Net margin
-36.2%
Diluted EPS
$-10.81
ROE
-175.0%
P/E (TTM)
—
Market cap
$1.67B
Debt / equity
1.9×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2023 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $2.72B | $2.70B | $2.84B | $2.84B | $3.06B |
| Gross profit | — | — | — | — | — |
| Operating income | $-872.6M | $-161.9M | $32.0M | $187.1M | $114.3M |
| Net income | $-986.2M | $-328.5M | $-25.2M | $186.2M | $98.0M |
| Diluted EPS | $-10.81 | $-3.67 | $-0.29 | $2.09 | $1.10 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-26
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →42026-06-12
View on EDGAR →Go deeper on FTRE
Search Fortrea Holdings Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.